On May 13, 2024, Inari Medical, Inc. was sued for violations of the federal securities laws in the United States District Court for the Southern District of New York on behalf of all purchasers of shares of the common stock of Inari between February 24, 2022 through February 28, 2024, inclusive (the “Class Period”).
We use cookies to improve your overall web experience. By using our website, you consent to the use of cookies in accordance with our Privacy Policy.